TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue22,385,00021,903,00019,652,00020,272,000
Cost of Revenue11,493,0009,661,0008,296,0009,216,000
Gross Profit10,892,00012,242,00011,356,00011,056,000
Operating Expenses
Research Development1,848,0002,111,0001,525,0001,488,000
Selling General and Administrative4,986,0005,145,0004,838,0005,078,000
Non Recurring----
Others80,00065,000-40,00024,000
Total Operating Expenses18,407,00016,982,00014,619,00015,806,000
Operating Income or Loss3,978,0004,921,0005,033,0004,466,000
Income from Continuing Operations
Total Other Income/Expenses Net-22,360,000-4,089,000-2,802,000-833,000
Earnings Before Interest and Taxes3,978,0004,921,0005,033,0004,466,000
Interest Expense-875,000-546,000-270,000-300,000
Income Before Tax-18,382,000832,0002,231,0003,633,000
Income Tax Expense-1,933,000521,000634,000591,000
Minority Interest1,386,0001,656,000158,00042,000
Net Income From Continuing Ops-16,449,000311,0001,597,0003,042,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,265,000329,0001,588,0003,055,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-16,525,00068,0001,573,0003,055,000